CMO
Bring your dossier and manufacturing requirements. We assess technology transfer, analytical readiness, batch scale and supply planning.
Transfer & manufactureSIKALIAS PHARMACEUTICAL LABORATORIES
Two complementary sites. One development partner.
GMP-certified Site 0 / EOF-authorized Site 1. Current site-specific scope and qualification documents are assessed for each project.
Science in every formulation. Care in every product.
From your formulation challenge to a defined manufacturing programme. Sikalias connects R&D, technology transfer and contract manufacturing in Athens: a European base for CMO, CDMO and nearshoring partnerships.
The right starting point for your next product
CDMO
Commission development or discuss a dossier in preparation, with manufacturing built into the programme from the start.
Develop & manufactureR&D materials
Present APIs, excipients, extracts and functional ingredients for our assigned development projects.
Introduce your materialsA European base for your next complex programme.
EUROPEAN CMO / CDMO · NEARSHORING
Nearshoring for complex molecules and biotechnology startups: from formulation and technology-transfer assessment to an agreed non-sterile manufacturing programme in Athens.
Built around the behaviour of your formulation
<10% RH
A low-humidity production room for moisture-sensitive powders and other suitable projects. The required operating conditions are defined for each process.
N₂
Nitrogen capability on selected liquid lines supports the control of oxygen exposure where the formulation and process require it.
Integrated automation
Production and packaging flows designed to reduce direct manual handling and support traceability and process consistency.
One technical conversation, from brief to batch
- 01Product brief
- 02Feasibility & scope
- 03Development / transfer
- 04Qualification & scale-up
- 05Manufacturing & supply
Responsibilities, specifications, timelines and commercial terms are agreed for the project. Manufacturing location and transfer arrangements follow the applicable authorisations and technical requirements.
Meet Stasinos Sikalias at CPHI Milan
6–7 October 2026 · Fiera Milano. Arrange a conversation about contract manufacturing, development or materials. Meetings are confirmed individually by email.
Request a meetingCompany presentationSee our development approach
EIREN and Firmie are being developed by Sikalias Pharmaceutical Laboratories. They are not yet available for sale and no launch date has been announced.
EIREN & Firmie · R&D ↗Development & Contract Manufacturing — CMO / CDMO
Start with dosage form, development stage, target market and estimated volume. Our team will assess the appropriate next step.
Discuss a projectR&D and responsible ingredient selection
Formulation development and reformulation bring together compatibility, stability, raw-material selection and specifications. Formulated Without is a brief-specific development policy, not a universal ranking of ingredient safety.
Our approachScience for families
The Why Lab connects everyday questions with observation and conversations between children and parents.
Explore the series